Original contributionA study of p53 protein, proliferating cell nuclear antigen, and p21 in Hodgkin's disease at presentation and relapse☆
References (29)
- et al.
Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphomaby Southern blot and in-situ hybridization
Blood
(1989) - et al.
Abnormal expression of p53-binding protein MDM2 in Hodgkin's disease
Blood
(1994) - et al.
WAF 1 a potential mediator of p53 tumor suppression
Cell
(1993) - et al.
p53 Function and dysfunction
Cell
(1992) - et al.
The E6 oncoprotein encoded by human papilloma virus types 16 and 18 promotes the degradation of p53
Cell
(1990) - et al.
The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations
Blood
(1993) - et al.
Large cell anaplastic lymphoma specific translocation t(2;5) (p23; q35) in Hodgkin's disease: Indication of a common pathogenesis
Lancet
(1995) - et al.
Clonal expansion of p53 mutant cells is associated with brain tumor progression
Nature
(1992) - et al.
Clinical Implications of the p53 tumor-suppressor gene
N Engl J Med
(1993) - et al.
The p53 tumor suppressor gene as a common target in human carcinogenesis
Am J Gastroenterol
(1993)
p53 mutations are associated with histologic transformation of follicular lymphomas
Blood
(1993)
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
Oncogene
(1994)
Growth suppression induced by wild type p53 protein is accompanied by selective down regulation of proliferating cell nuclear cell antigen expression
The p53 tumor suppressor gene
Nature
(1991)
Cited by (21)
Bone marrow in Hodgkin lymphoma and mimickers
2013, Bone Marrow Lymphoid Infiltrates: Diagnosis and Clinical ImpactPathobiology of Hodgkin lymphoma
2011, Advances in HematologyPathogenesis and first-line treatment of Hodgkin's lymphoma
2011, Acta Haematologica PolonicaProliferating cell nuclear antigen (PCNA), p53 and MDM2 expression in Hodgkins disease
2007, Sao Paulo Medical JournalNo influence of bcl-2, p53, and p21waf1 protein expression on the outcome of pediatric Hodgkin lymphomas
2006, Journal of Pediatric Hematology/Oncology
- ☆
This work was carried out during an exchange fellowship program at the National Cancer Institute, Bethesda. There are no restrictions on its use.
Copyright © 1997 Published by Elsevier Inc.